| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |